|
Canada-0-Engineering شركة الأدلة
|
شركة أخبار :
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . .
Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double-blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
- Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical . . .
ASPEN-1 was a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy, duration of response, and safety of 2 doses of DaxibotulinumtoxinA for Injection (DAXI), a novel botulinum toxin type A formulation in participants with cervical dystonia (CD)
- Treatment with botulinum toxin type A for people with involuntary . . .
Currently, botulinum toxin type A (BtA) is considered the first line therapy for this condition To compare the efficacy, safety, and tolerability of BtA versus placebo, in people with cervical dystonia
- Efficacy and safety of botulinum type A toxin (Dysport) in cervical . . .
Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States
- Long-term efficacy and safety of botulinum toxin type A (Dysport) in . . .
The aim of this study was to evaluate the efficacy and safety of intramuscular (IM) administration of botulinum toxin type A (Dysport ®, Ipsen Biopharm Ltd ) for the treatment of cervical dystonia (CD) and the long-term safety and efficacy of repeated treatments
- Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based . . .
Several studies, including nearly two dozen randomized clinical trials, have shown that botulinum toxin is safe and effective in reducing the clinical severity of cervical dystonia Longitudinal data have demonstrated decades of sustained benefit and safety
- Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN
The objective of this study was to compare the safety and efficacy of incobotulinumtoxinA (120U, 240U; Merz Pharmaceuticals) to placebo in subjects with cervical dystonia (CD)
- High-dose Botulinum Toxin Therapy: Safety, Benefit, and Endurance of . . .
We aimed to evaluate safety, benefit, and efficacy of patients receiving OnaA >400 U per visit We hypothesized that higher OnaA doses would be well-tolerated and effective and provide lasting benefit
- Cervical dystonia — improving the effectiveness of botulinum toxin . . .
A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia
- 33 - Botulinum Toxin Therapy for Cervical Dystonia
Factors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled study
|
|